Stocktoria
BALCHEM CORP BCPC
Nasdaq · XNAS · stock · Chemicals & Allied Products · website · IPO 1986-06-03
BALCHEM CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.0B | $953.7M | $922.4M | $942.4M | $799.0M |
| Gross profit | $370.6M | $336.2M | $302.1M | $280.5M | $243.2M |
| R&D expense | $18.5M | $16.8M | $15.0M | $12.2M | $13.5M |
| Operating income | $209.3M | $182.9M | $159.2M | $145.2M | $127.5M |
| Income tax | $44.2M | $38.0M | $28.7M | $28.4M | $29.1M |
| Net income | $154.8M | $128.5M | $108.5M | $105.4M | $96.1M |
| EPS (diluted) | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 |
| Operating cash flow | $216.6M | $182.0M | $183.8M | $138.5M | $160.5M |
| Free cash flow | — | — | — | $89.5M | $124.4M |
| Cash & equivalents | $74.6M | $49.5M | $64.4M | $66.6M | $103.2M |
| Inventory | $131.4M | $130.8M | $109.5M | $119.7M | $91.1M |
| Total assets | $1.7B | $1.6B | $1.6B | $1.6B | $1.2B |
| Total liabilities | $428.8M | $425.5M | $543.2M | $686.2M | $322.3M |
| Shareholders' equity | $1.3B | $1.1B | $1.1B | $938.3M | $877.0M |
Source: SEC EDGAR filings · CIK 0000009326 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.